Gustavo Trossini

Dr. Gustavo Trossini

Departamento de Farmácia, Universidade de São Paulo, Sao Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2023 in Molecular Informatics
Verified
Journal Article
Closed access
ASArtur Caminero Gomes Soares
Artur Caminero Gomes Soares
GSGustavo Henrique Marques Sousa
Gustavo Henrique Marques Sousa
RCRaisa Ludmila Calil
Raisa Ludmila Calil
GTGustavo Trossini
Gustavo Trossini

13 August 2020 in Future Medicinal Chemistry
Verified
Journal Article
Open access
WFWitor Ribeiro Ferraz
Witor Ribeiro Ferraz
RGRenan Augusto Gomes
Renan Augusto Gomes
ANAndre Luis S Novaes
Andre Luis S Novaes
GTGustavo Trossini
Gustavo Trossini
Aim: The identification of drugs for the coronavirus disease-19 pandemic remains urgent. In this manner, drug repurposing is a suitable strategy, saving resources and time normally spent during reg... Graphical abstract

1 May 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FLFranco Leite
Franco Leite
TFThamires Froes
Thamires Froes
SSSuellen Gonçalves da Silva
Suellen Gonçalves da Silva
ESEvandro Italo Macêdo de Souza
Evandro Italo Macêdo de Souza
DVDrielli Gomes Vital-Fujii
Drielli Gomes Vital-Fujii
MCMarcelo Castilho
Marcelo Castilho

2 August 2016 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
RGRenan A. Gomes
Renan A. Gomes
GGGiovani L. Genesi
Giovani L. Genesi
VMVinicius G. Maltarollo
Vinicius G. Maltarollo
GTGustavo Trossini
Gustavo Trossini
(2017). Quantitative structure–activity relationships (HQSAR, CoMFA, and CoMSIA) studies for COX-2 selective inhibitors. Journal of Biomolecular Structure and Dynamics: Vol. 35, No. 7, pp. 1436-1445.

2 December 2015 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
GTGustavo Trossini
Gustavo Trossini
VMVinicius G. Maltarollo
Vinicius G. Maltarollo
RGRicardo D’a. Garcia
Ricardo D’a. Garcia
CPClaudinéia A. S. O. Pinto
Claudinéia A. S. O. Pinto
MVMaria V. R. Velasco
Maria V. R. Velasco
André BabyAndré Baby
André Baby

23 December 2009 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
GTGustavo Trossini
Gustavo Trossini
AMAlberto Malvezzi
Alberto Malvezzi
AAAntonia Tavares Do Amaral
Antonia Tavares Do Amaral
CRCARLOTA RANGEL-YAGUI
CARLOTA RANGEL-YAGUI
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
EFElizabeth Igne Ferreira
Elizabeth Igne Ferreira
Nitrofurazone (NF) and its derivative, hydroxymethylnitrofurazone (NFOH), have presented antichagasic activity. NFOH has higher activity and lower mutagenicity. The aim of this work was to assess whether NF and its derivative NFOH would also be inhibitors of cruzain, besides their trypanothione reductase inhibitory activity. In vitro cruzain inhibition tests were performed for both compounds, and the 50% inhibitory concentration (IC50) for NF and NFOH presented values of 22.83 ± 1.2 μM and 10.55 ± 0.81 μM, respectively. AM1 semi-empirical molecular modeling studies were performed to understand the activity of the compounds, corroborating the observed cruzain inhibitory activity.